Latest Share Chat

MTPH.L Share News (MTPH)

MTPH.L Information

There is currently no data for MTPH

Midatech inks evaluation agreement with Asian pharma outfit

Thu, 20th Dec 2018 10:12

(Sharecast News) - Pharmaceutical research and development outfit Midatech has inked an agreement with an unnamed company to evaluate its Q-Sphera drug delivery platform.Midatech will work with its mystery partner on its Q-Sphera platform, which allows drug compounds to be released into the body in a "highly controlled manner" over a prolonged period of time, first conducting a feasibility program using the technology.Chief executive Dr Craig Cook, said: "This marks another important step in the development of our impressive Q-Sphera technology, after the positive clinical 'proof of concept' first-in-human study earlier this year in carcinoid cancer and acromegaly."Elsewhere, Midatech revealed that it was currently in "advanced discussions" with a new Asia-based strategic investor regarding a potential £8m investment in the firm.In addition to the investment, the AIM-listed firm will issue an undisclosed amount of shares at 50p each as part of an offer in order to raise more funds for expected scale-up costs associated with the manufacture of its lead development product MTD201, a treatment for carcinoid cancer and acromegaly.As of 1010 GMT, Midatech shares had shot up 10.24% to 6.89p.

More News

23 Apr 2018 11:02

Midatech Pharma 2017 Loss Narrows On Costs And Impairments Fall

LONDON (Alliance News) - Midatech Pharma PLC said Monday its 2017 loss narrowed on lower costs and reduced impairments as its approaches 2018 with a number of key "inflection" points for

15 Mar 2018 12:36

Midatech Pharma CEO Phillips To Step Down, COO Cook Steps Up

LONDON (Alliance News) - Pharmaceutical firm Midatech Pharma PLC said Thursday its Chief Executive Jim Phillips will leave the company after five years at the who is departing

22 Nov 2016 13:29

Midatech Pharma receives upfront access fee

(ShareCast News) - International speciality pharmaceutical company Midatech Pharma said it has received an upfront technology access fee and option payment of £450,000. This was under the terms of the exclusive licence granted to Emergex Vaccines Ltd. This licence covered the use of Midatech's prop

15 Nov 2016 12:04

Midatech Pharma chooses MTR104 for liver cancer treatment

(ShareCast News) - International speciality pharmaceutical company Midatech Pharma has selected its candidate compound MTR104 to take into a formal IND-enabling programme during 2017. This would be followed by human studies planned for 2018, the company said. "The programme is focused on advanced l

31 Oct 2016 09:39

BROKER RATINGS SUMMARY: HSBC Raises IAG To Hold From Reduce

11 Oct 2016 10:30

Midatech To Raise GBP14 Million Via Placing And Open Offer (ALLISS)

30 Sep 2016 08:41

Midatech Says Trials Of Drug Using Its Gold Nanoparticles Commence

2 Sep 2016 12:07

Midatech Pharma's revenues increases due to US sales

(ShareCast News) - Midatech Pharma's half-year revenues increased significantly, with management sounding an optimistic note regarding the potential of the company´s research and development programmes. For the six months ended 30 June, revenue increased significantly to £3.8m from £320,000 in the s

7 Jul 2016 09:05

Latest Share Chat

MTPH.L Share News (MTPH)

Midatech inks evaluation agreement with Asian pharma outfit

Midatech Pharma 2017 Loss Narrows On Costs And Impairments Fall

Midatech Pharma CEO Phillips To Step Down, COO Cook Steps Up

Midatech Pharma receives upfront access fee

Midatech Pharma chooses MTR104 for liver cancer treatment

BROKER RATINGS SUMMARY: HSBC Raises IAG To Hold From Reduce

Midatech To Raise GBP14 Million Via Placing And Open Offer (ALLISS)

Midatech Says Trials Of Drug Using Its Gold Nanoparticles Commence

Midatech Pharma's revenues increases due to US sales

Midatech-Cardiff University Collaboration Gets Diabetes Grant

Midatech Pharma Issues Final Shares To Settle Q Chip Acquisition (ALLISS)

Midatech Signals Further Focus On "Better Suited" Oncology Treatments

Midatech Pharma Trading Ahead Of Expectations On Strong Revenue Growth

Midatech Pharma Gets Positive Data From Q-Octreotide Trial

Midatech Pharma Sees Positive Dosing Data In Uveitis Programme

Midatech Loss Widens On Acquisition Costs, But Revenue Surges

Latest Share Chat

MTPH.L Share News (MTPH)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Midatech inks evaluation agreement with Asian pharma outfit

Login to your account

Quickpicks are a member only feature

Login to your account